Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698229 · ClinicalTrials.gov registry record

Collection of Cerebrospinal Fluid in Healthy Children

A clinical trial, sponsored by Weill Medical College of Cornell University.

Terminated
Registry status
32
Enrollment target

NCT01698229 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698229 was terminated before completion, sponsored by Weill Medical College of Cornell University.

TERMINATED
Registry status
32 participants
Enrollment target

Study Summary

The purpose of this study is to obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.

Interventions

  • OTHER Group 1

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2011-12
Est. Completion 2015-12

What the Registry Record Tells You About NCT01698229

The ClinicalTrials.gov registry entry for NCT01698229 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Group 1 is the first listed.

NCT01698229 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01698229 about?

NCT01698229 is a clinical study titled "Collection of Cerebrospinal Fluid in Healthy Children". The purpose of this study is to obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerativ...

What is the current status of trial NCT01698229?

This trial is currently terminated. The enrollment target is 32 participants. The study started on 2011-12. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01698229?

The interventions under investigation include: Group 1 (OTHER).

Who is sponsoring clinical trial NCT01698229?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.